- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 5 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
DU0.2: 14 residues within 4Å:- Chain A: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.3, MC3.6, MC3.7
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.65, A:L.252
DU0.14: 14 residues within 4Å:- Chain B: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.15, MC3.18, MC3.19
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.65, B:L.252
DU0.26: 14 residues within 4Å:- Chain C: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.27, MC3.30, MC3.31
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.65, C:L.252
DU0.39: 14 residues within 4Å:- Chain D: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.40, MC3.43, MC3.44
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:L.65, D:L.252
DU0.51: 14 residues within 4Å:- Chain E: F.42, L.46, L.54, G.57, Q.58, Y.61, F.62, L.65, L.249, L.252, I.253
- Ligands: MC3.52, MC3.55, MC3.56
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:L.65, E:L.252
- 50 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
MC3.3: 20 residues within 4Å:- Chain A: E.35, C.38, F.39, F.42, I.242, Y.245, S.246, F.248, L.249, L.252, F.281
- Chain D: F.14, G.15, S.18, Q.19, L.21, L.22, L.279
- Ligands: DU0.2, MC3.42
Ligand excluded by PLIPMC3.4: 8 residues within 4Å:- Chain A: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.5
Ligand excluded by PLIPMC3.5: 11 residues within 4Å:- Chain A: L.21, L.22, L.23, W.24, R.25, Y.29, W.33, L.36, F.282
- Ligands: MC3.4, MC3.52
Ligand excluded by PLIPMC3.6: 9 residues within 4Å:- Chain A: Y.61, L.65, L.249, I.253
- Chain D: L.271, I.275, F.276
- Ligands: DU0.2, MC3.48
Ligand excluded by PLIPMC3.7: 9 residues within 4Å:- Chain A: F.42, A.45, L.46, A.49, V.53, L.54, Q.58
- Ligands: DU0.2, MC3.8
Ligand excluded by PLIPMC3.8: 6 residues within 4Å:- Chain A: A.45, A.48, F.52, V.53
- Ligands: MC3.7, MC3.9
Ligand excluded by PLIPMC3.9: 7 residues within 4Å:- Chain A: G.41, M.44, A.45, A.48, F.52
- Ligands: MC3.8, MC3.12
Ligand excluded by PLIPMC3.10: 8 residues within 4Å:- Chain A: W.33, R.34, L.37, C.38, G.41
- Chain D: R.13, F.14, G.15
Ligand excluded by PLIPMC3.11: 7 residues within 4Å:- Chain A: D.270, L.271, C.272, V.273, I.275
- Chain E: Y.61
- Ligands: MC3.55
Ligand excluded by PLIPMC3.12: 7 residues within 4Å:- Chain A: M.44, S.47, A.48, R.51, F.52, C.272
- Ligands: MC3.9
Ligand excluded by PLIPMC3.15: 20 residues within 4Å:- Chain B: E.35, C.38, F.39, F.42, I.242, Y.245, S.246, F.248, L.249, L.252, F.281
- Chain C: F.14, G.15, S.18, Q.19, L.21, L.22, L.279
- Ligands: DU0.14, MC3.29
Ligand excluded by PLIPMC3.16: 8 residues within 4Å:- Chain B: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.17
Ligand excluded by PLIPMC3.17: 11 residues within 4Å:- Chain B: L.21, L.22, L.23, W.24, R.25, Y.29, W.33, L.36, F.282
- Ligands: MC3.16, MC3.40
Ligand excluded by PLIPMC3.18: 9 residues within 4Å:- Chain B: Y.61, L.65, L.249, I.253
- Chain C: L.271, I.275, F.276
- Ligands: DU0.14, MC3.35
Ligand excluded by PLIPMC3.19: 9 residues within 4Å:- Chain B: F.42, A.45, L.46, A.49, V.53, L.54, Q.58
- Ligands: DU0.14, MC3.20
Ligand excluded by PLIPMC3.20: 6 residues within 4Å:- Chain B: A.45, A.48, F.52, V.53
- Ligands: MC3.19, MC3.21
Ligand excluded by PLIPMC3.21: 7 residues within 4Å:- Chain B: G.41, M.44, A.45, A.48, F.52
- Ligands: MC3.20, MC3.23
Ligand excluded by PLIPMC3.22: 7 residues within 4Å:- Chain B: D.270, L.271, C.272, V.273, I.275
- Chain D: Y.61
- Ligands: MC3.43
Ligand excluded by PLIPMC3.23: 7 residues within 4Å:- Chain B: M.44, S.47, A.48, R.51, F.52, C.272
- Ligands: MC3.21
Ligand excluded by PLIPMC3.24: 8 residues within 4Å:- Chain B: W.33, R.34, L.37, C.38, G.41
- Chain C: R.13, F.14, G.15
Ligand excluded by PLIPMC3.27: 20 residues within 4Å:- Chain C: E.35, C.38, F.39, F.42, I.242, Y.245, S.246, F.248, L.249, L.252, F.281
- Chain E: F.14, G.15, S.18, Q.19, L.21, L.22, L.279
- Ligands: DU0.26, MC3.54
Ligand excluded by PLIPMC3.28: 8 residues within 4Å:- Chain C: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.29
Ligand excluded by PLIPMC3.29: 11 residues within 4Å:- Chain C: L.21, L.22, L.23, W.24, R.25, Y.29, W.33, L.36, F.282
- Ligands: MC3.15, MC3.28
Ligand excluded by PLIPMC3.30: 9 residues within 4Å:- Chain C: Y.61, L.65, L.249, I.253
- Chain E: L.271, I.275, F.276
- Ligands: DU0.26, MC3.60
Ligand excluded by PLIPMC3.31: 9 residues within 4Å:- Chain C: F.42, A.45, L.46, A.49, V.53, L.54, Q.58
- Ligands: DU0.26, MC3.32
Ligand excluded by PLIPMC3.32: 6 residues within 4Å:- Chain C: A.45, A.48, F.52, V.53
- Ligands: MC3.31, MC3.33
Ligand excluded by PLIPMC3.33: 7 residues within 4Å:- Chain C: G.41, M.44, A.45, A.48, F.52
- Ligands: MC3.32, MC3.36
Ligand excluded by PLIPMC3.34: 8 residues within 4Å:- Chain C: W.33, R.34, L.37, C.38, G.41
- Chain E: R.13, F.14, G.15
Ligand excluded by PLIPMC3.35: 7 residues within 4Å:- Chain B: Y.61
- Chain C: D.270, L.271, C.272, V.273, I.275
- Ligands: MC3.18
Ligand excluded by PLIPMC3.36: 7 residues within 4Å:- Chain C: M.44, S.47, A.48, R.51, F.52, C.272
- Ligands: MC3.33
Ligand excluded by PLIPMC3.40: 20 residues within 4Å:- Chain B: F.14, G.15, S.18, Q.19, L.21, L.22, L.279
- Chain D: E.35, C.38, F.39, F.42, I.242, Y.245, S.246, F.248, L.249, L.252, F.281
- Ligands: MC3.17, DU0.39
Ligand excluded by PLIPMC3.41: 8 residues within 4Å:- Chain D: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.42
Ligand excluded by PLIPMC3.42: 11 residues within 4Å:- Chain D: L.21, L.22, L.23, W.24, R.25, Y.29, W.33, L.36, F.282
- Ligands: MC3.3, MC3.41
Ligand excluded by PLIPMC3.43: 9 residues within 4Å:- Chain B: L.271, I.275, F.276
- Chain D: Y.61, L.65, L.249, I.253
- Ligands: MC3.22, DU0.39
Ligand excluded by PLIPMC3.44: 9 residues within 4Å:- Chain D: F.42, A.45, L.46, A.49, V.53, L.54, Q.58
- Ligands: DU0.39, MC3.45
Ligand excluded by PLIPMC3.45: 6 residues within 4Å:- Chain D: A.45, A.48, F.52, V.53
- Ligands: MC3.44, MC3.46
Ligand excluded by PLIPMC3.46: 7 residues within 4Å:- Chain D: G.41, M.44, A.45, A.48, F.52
- Ligands: MC3.45, MC3.49
Ligand excluded by PLIPMC3.47: 8 residues within 4Å:- Chain B: R.13, F.14, G.15
- Chain D: W.33, R.34, L.37, C.38, G.41
Ligand excluded by PLIPMC3.48: 7 residues within 4Å:- Chain A: Y.61
- Chain D: D.270, L.271, C.272, V.273, I.275
- Ligands: MC3.6
Ligand excluded by PLIPMC3.49: 7 residues within 4Å:- Chain D: M.44, S.47, A.48, R.51, F.52, C.272
- Ligands: MC3.46
Ligand excluded by PLIPMC3.52: 20 residues within 4Å:- Chain A: F.14, G.15, S.18, Q.19, L.21, L.22, L.279
- Chain E: E.35, C.38, F.39, F.42, I.242, Y.245, S.246, F.248, L.249, L.252, F.281
- Ligands: MC3.5, DU0.51
Ligand excluded by PLIPMC3.53: 8 residues within 4Å:- Chain E: W.24, W.33, R.34, L.36, L.37, L.40, L.278
- Ligands: MC3.54
Ligand excluded by PLIPMC3.54: 11 residues within 4Å:- Chain E: L.21, L.22, L.23, W.24, R.25, Y.29, W.33, L.36, F.282
- Ligands: MC3.27, MC3.53
Ligand excluded by PLIPMC3.55: 9 residues within 4Å:- Chain A: L.271, I.275, F.276
- Chain E: Y.61, L.65, L.249, I.253
- Ligands: MC3.11, DU0.51
Ligand excluded by PLIPMC3.56: 9 residues within 4Å:- Chain E: F.42, A.45, L.46, A.49, V.53, L.54, Q.58
- Ligands: DU0.51, MC3.57
Ligand excluded by PLIPMC3.57: 6 residues within 4Å:- Chain E: A.45, A.48, F.52, V.53
- Ligands: MC3.56, MC3.58
Ligand excluded by PLIPMC3.58: 7 residues within 4Å:- Chain E: G.41, M.44, A.45, A.48, F.52
- Ligands: MC3.57, MC3.61
Ligand excluded by PLIPMC3.59: 8 residues within 4Å:- Chain A: R.13, F.14, G.15
- Chain E: W.33, R.34, L.37, C.38, G.41
Ligand excluded by PLIPMC3.60: 7 residues within 4Å:- Chain C: Y.61
- Chain E: D.270, L.271, C.272, V.273, I.275
- Ligands: MC3.30
Ligand excluded by PLIPMC3.61: 7 residues within 4Å:- Chain E: M.44, S.47, A.48, R.51, F.52, C.272
- Ligands: MC3.58
Ligand excluded by PLIP- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-2: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
EC
AD
DE
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 5 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
- 50 x MC3: 1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Owji, A.P. et al., Structures and gating mechanisms of human bestrophin anion channels. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Bestrophin-2: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
EC
AD
DE
B - Membrane
-
We predict this structure to be a membrane protein.